Research Information System
19. ULUSAL DERMATOLOJİ KONGRESİ, Antalya, Turkey, 2 July - 07 September 2002, vol.43, (Unpublished)
Background Systemic antibiotics currently used in the treatment of rosacea are sometimes associated with uncomfortable side-effects. Therefore, a need for an effective agent with few side-effects and good patient compliance exists. Azithromycin, a macrolide antibiotic with prolonged mode of action, has recently been found to be an effective alternative in the treatment of inflammatory acne. We planned a study to evaluate the efficacy and safety of azithromycin in rosacea.